The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine.

ABSTRACT: Radionuclide imaging of myocardial perfusion, function, and viability has been established for decades and remains a robust, evidence-based and broadly available means for clinical workup and therapeutic guidance in ischemic heart disease. Yet, powerful alternative modalities have emerged for this purpose, and their growth has resulted in increasing competition. But the potential of the tracer principle goes beyond the assessment of physiology and function, toward the interrogation of biology and molecular pathways. This is a unique selling point of radionuclide imaging, which has been underrecognized in cardiovascular medicine until recently. Now, molecular imaging methods for the detection of myocardial infiltration, device infection, and cardiovascular inflammation are successfully gain

SUBMITTER: Werner RA 

PROVIDER: S-EPMC7383072 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature